2,3-Dichloro-N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]benzamide structure
|
Common Name | 2,3-Dichloro-N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]benzamide | ||
|---|---|---|---|---|
| CAS Number | 168079-33-2 | Molecular Weight | 476.3 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H19Cl2N3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 2,3-Dichloro-N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]benzamide |
|---|
| Molecular Formula | C26H19Cl2N3O2 |
|---|---|
| Molecular Weight | 476.3 |
| InChIKey | VSWXVCQKGPRJIB-UHFFFAOYSA-N |
| SMILES | O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1cccc(Cl)c1Cl |
|
Name: Inhibition of [3H]AVP binding to Dawley rat kidney medullary vasopressin V2 receptor.
Source: ChEMBL
Target: Vasopressin V2 receptor
External Id: CHEMBL818808
|
|
Name: Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
Source: ChEMBL
Target: Vasopressin V1a receptor
External Id: CHEMBL820172
|